(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study).

导出 OA

翻译打印收藏纠错

作者： Anouk A,Kruiswijk ^[1] ; Michiel A J,van de Sande ^[2] ; Rick L,Haas ^[2] ; Elske M,van den Akker-van Marle ^[3] ; Ellen G,Engelhardt ^[4] ; Perla,Marang-van de Mheen ^[5] ; Leti,van Bodegom-Vos ^[4] ; VALUE-PERSARC research group ^[4]

作者单位： Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands a.a.kruiswijk@lumc.nl. ^[1] Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands. ^[2] Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[3] Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. ^[4] Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[5]

关键词 oncology quality in health care sarcoma

主题词人类(Humans);男(雄)性(Male);女(雌)性(Female);肉瘤(Sarcoma);线性模型(Linear Models);危险性评估(Risk Assessment);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1136/bmjopen-2023-074853

PMID 37918933

发布时间 2023-11-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交